Press Releases Vapotherm, Inc.

Equities

VAPO

US9221073052

Delayed OTC Markets Other stock markets 13:44:27 2024-05-10 EDT			5-day change	1st Jan Change
1.122 ^USD	-15.00%		-11.65%	+12.20%

05-09	Vapotherm, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-01	Vapotherm, Inc. Enters into Amendment No. 7 to Loan and Security Agreement with SLR Investment Corp	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vapotherm: Q1 Earnings Snapshot	05-09	AQ
Vapotherm Reports First Quarter 2024 Financial Results	05-09	PR
Vapotherm : Onymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT)	03-20	PU
Vapotherm, Inc. - Dr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study	03-07	AQ
Vapotherm: Q4 Earnings Snapshot	02-22	AQ
Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial Results	02-22	PR
Vapotherm : Overview	12-19	PU
OTC Markets Group Welcomes Vapotherm, Inc. to OTCQX	12-15	AQ
Vapotherm Announces Suspension of NYSE Listing Common Stock Expected to Begin Trading Promptly on OTCQX	12-14	PR
Vapotherm Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock Application Pending to Transfer Shares to OTCQX	12-11	PR
Vapotherm Educates over 8,000 Clinicians in Respiratory Care Month	11-29	AQ
Vapotherm Reports Third Quarter 2023 Financial Results	11-09	AQ
Vapotherm: Q3 Earnings Snapshot	11-08	AQ
Vapotherm : Overview	23-10-11	PU
Computational Fluid Dynamics modeling further distinguishes Vapotherm High Velocity Therapy from generic high flow cannulas	23-10-05	AQ
Computational Fluid Dynamics (CFD) modeling further distinguishes Vapotherm High Velocity Therapy from generic high flow cannulas	23-10-04	BU
Pilot Study demonstrates Vapotherm HVNI technology is more effective than standard oxygen therapy for treatment of acute asthma in children	23-09-25	BU
Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive, Adam Hodges, as Vice President, Sales and Marketing	23-09-11	AQ
Vapotherm: Q2 Earnings Snapshot	23-08-08	AQ
Vapotherm Reports Second Quarter 2023 Financial Results	23-08-08	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Vapotherm, Inc.

Equities

VAPO

US9221073052

Press Releases

Filters